Disclaimer

The link you have chosen leads to a site maintained by a third party over whom Novartis has no control. As such, Novartis makes no representation as to the accuracy or any other aspect of the information on this site.

OKCancel

The clinical use in these resources may not be consistent with the approved indications for Glivec. The information in these resources is not country-specific and may contain information that is outside the approved indications where you practice. Please contact your local Novartis representative for the latest product information specific to your country.

folder image

Learn more about GLIVEC by viewing, downloading, and/or printing the following materials

Clinical studies and overviews

Scandinavian Sarcoma Group adjuvant trial update (2012)

View study View study image

Treatment interruption vs continuation in advanced GIST (2007)

View abstract View abstract image

Adjuvant GLIVEC after resection (Z9001 trial results) (2009)

View abstract View abstract image

GLIVEC dose comparison in mutational GIST (2010)

View abstract View abstract image

GLIVEC dose optimization in unresectable and metastatic KIT+ GIST (2008)

View abstract View abstract image